Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,59 USD | -1,85% | +1,92% | +85,10% |
Omzet 2024 * | 79,33K 73,59K | Omzet 2025 * | 100K 92,77K | Marktkapitalisatie | 133 mln. 123 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -98 mln. -90,91 mln. | Nettowinst (verlies) 2025 * | -94 mln. -87,2 mln. | EV/omzet 2024 * | 1.377 x |
Nettoliquiditeiten 2024 * | 23,5 mln. 21,8 mln. | Nettoliquiditeiten 2025 * | 57,78 mln. 53,6 mln. | EV/omzet 2025 * | 749 x |
K/w-verhouding 2024 * |
-1,31
x | K/w-verhouding 2025 * |
-2,04
x | Werknemers | 138 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 77,03% |
Recentste transcriptie over NGM Biopharmaceuticals, Inc.
1 dag | -1,85% | ||
1 week | +1,92% | ||
Lopende maand | +4,61% | ||
1 maand | +3,92% | ||
3 maanden | +76,67% | ||
6 maanden | +51,43% | ||
Lopend jaar | +85,10% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Woodhouse
CEO | Chief Executive Officer | 54 | 02-03-15 |
William Rieflin
CHM | Chairman | 64 | 01-09-10 |
Daniel Kaplan
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 71 | 08-06-21 | |
David Goeddel
BRD | Director/Board Member | 72 | 01-01-08 |
William Rieflin
CHM | Chairman | 64 | 01-09-10 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - | |
0.00% | 9 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,59 | -1,85% | 357 153 |
27-03-24 | 1,62 | +4,52% | 3 296 613 |
26-03-24 | 1,55 | 0,00% | 771 033 |
25-03-24 | 1,55 | 0,00% | 1 363 296 |
22-03-24 | 1,55 | -0,64% | 1 557 947 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+85,10% | 135 mln. | |
+2,73% | 108 mld. | |
+9,59% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,59% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,29% | 16,19 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,22 mld. |